Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Haruna Kawano"'
Autor:
Mitsuhiro Tambo, Shigeo Horie, Shinya Kaname, Toshihito Furukawa, Tatsuya Yoshioka, Satoru Taguchi, Tsuyoshi Yamaguchi, Haruna Kawano, Eiji Higashihara, Satoru Muto, Hiroshi Fukuhara, Kenich Yokoyama
Publikováno v:
American Journal of Nephrology. 51:881-890
Background: Tolvaptan was approved for the treatment of autosomal dominant polycystic kidney disease (ADPKD). However, the official indication of “rapidly progressive disease” is described differently in the clinical guidelines. We aim to define
Autor:
Kengo Furuichi, Kenichiro Miura, Keiji Shimazu, Hiroki Hayashi, Taketsugu Hama, Daisuke Ichikawa, Sumi Hidaka, Eiji Ishikawa, Soshiro Ogata, Koichi Seta, Kiyotaka Uchiyama, Kazushige Hanaoka, Eri Koshi-Ito, Shigeo Horie, Yoshikatsu Kaneko, Mahiro Kurashige, Shinya Nakatani, Ichiei Narita, Ken Tsuchiya, Shiho Makabe, Toshio Mochizuki, Hirayasu Kai, Hiroshi Kataoka, Akinari Sekine, Haruna Kawano, Hirokazu Okada, Satoru Muto, Koichi Nakanishi, Tatsuya Suwabe, Saori Nishio, Michihiro Mitobe
Publikováno v:
Clinical and experimental nephrology. 25(12)
Autor:
Tadashi Okada, Shigeo Horie, Yoshiyuki Shibasaki, Tatsuki Ibuki, Koji Nakajima, Satoru Muto, Haruna Kawano
Publikováno v:
Clinical and Experimental Nephrology
Background Tolvaptan slowed the rates of total kidney volume (TKV) growth and renal function decline over a 3-year period in patients with autosomal dominant polycystic kidney disease (ADPKD) enrolled in the Tolvaptan Efficacy and Safety in Managemen
Autor:
Peter C. Harris, Isao Miyazaki, Takatsugu Okegawa, Shinya Kaname, Mitsuhiro Tanbo, Haruna Kawano, Hidehiko Hara, Kikuo Nutahara, Shigeo Horie, Kaori Shigemori, Tsuyoshi Yamaguchi, Moritoshi Kinoshita, Eiji Higashihara
Publikováno v:
Clinical and Experimental Nephrology
Background Autosomal dominant polycystic disease (ADPKD) often results in renal failure. Recently, allelic influences of PKD1 mutation types on renal survival were extensively investigated. Here, we analyzed integrated influences of PKD1 mutation typ
Autor:
Haruna Kawano, William A. Prinz, Nicholas P. Restifo, Yu Ishimoto, Shigeo Horie, Li-Ka Liu, Patricia Outeda, Fang Zhou, Tanchun Wang, Takeshi Terabayashi, Vineet Choudhary, Yi Liu, Luis F. Menezes, Cheng-Chao Lin, Ryan Hobbs, Mahiro Kurashige, Gregory G. Germino, Terry Watnick, Hong Xu, Ping-Hsien Lee
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-19 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-19 (2018)
Recent studies have reported intrinsic metabolic reprogramming in Pkd1 knock-out cells, implicating dysregulated cellular metabolism in the pathogenesis of polycystic kidney disease. However, the exact nature of the metabolic changes and their underl
Publikováno v:
Clinical and experimental nephrology. 22(3)
We assessed the effectiveness and convenience of a novel semi-automatic kidney volume (KV) measuring high-speed 3D-image analysis system SYNAPSE VINCENT® (Fuji Medical Systems, Tokyo, Japan) for autosomal dominant polycystic kidney disease (ADPKD) p
Autor:
Eiji Higashihara, Takafumi Fukui, Krisztina Rigo, Moritoshi Kinoshita, Kiyonori Katsuragi, Tim Hague, Kozo Kawahara, Nobuhisa Gondo, Masahiko Takeshi, Kimiyoshi Sudo, Takehiko Oka, Shigeo Horie, Ryo Higashiyama, Haruna Kawano, Kikuo Nutahara, Daisuke Koga
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 11, p e0166288 (2016)
PLoS ONE, Vol 11, Iss 11, p e0166288 (2016)
Genetic testing of PKD1 and PKD2 is expected to play an increasingly important role in determining allelic influences in autosomal dominant polycystic kidney disease (ADPKD) in the near future. However, to date, genetic testing is not commonly employ
Autor:
John Ouyang, Eiji Higashihara, Satoru Muto, Yoshifumi Ubara, Takayuki Matsuzaki, Ichiei Narita, Haruna Kawano, Vicente E. Torres, Shigeo Horie
Publikováno v:
Clinical and experimental nephrology. 19(5)
Japan is the first country in the world to approve tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD), which was based on the results of Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kid
Autor:
Fusako Iwata, Toyoki Mori, Haruna Kawano, Yasukazu Ohmoto, Lu Yan, Hiroyuki Fujiki, Satoru Muto, Shigeo Horie
Publikováno v:
Clinical and experimental nephrology. 19(5)
Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disease, is a progressive disease characterized by a bilateral proliferation and enlargement of renal cysts. Recent reports have shown that tolvaptan, a vasopressi